Which has higher valuation & earnings, TDOC or AMZN?

Amazon.com has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Amazon.com, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Teladoc Health $2.53B 0.66 -$200.32M -$0.97 N/A Amazon.com $716.92B 3.64 $77.67B $8.36 29.03

Does the media refer more to TDOC or AMZN?

In the previous week, Amazon.com had 267 more articles in the media than Teladoc Health. MarketBeat recorded 276 mentions for Amazon.com and 9 mentions for Teladoc Health. Amazon.com's average media sentiment score of 0.88 beat Teladoc Health's score of 0.49 indicating that Amazon.com is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 3 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Amazon.com 160 Very Positive mention(s) 43 Positive mention(s) 43 Neutral mention(s) 23 Negative mention(s) 6 Very Negative mention(s) Positive

Does the media prefer CRSP or TDOC?

In the previous week, Teladoc Health had 2 more articles in the media than CRISPR Therapeutics. MarketBeat recorded 9 mentions for Teladoc Health and 7 mentions for CRISPR Therapeutics. CRISPR Therapeutics' average media sentiment score of 1.05 beat Teladoc Health's score of 0.49 indicating that CRISPR Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CRISPR Therapeutics 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Teladoc Health 3 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings and valuation, TDOC or ROKU?

Roku has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Roku, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Teladoc Health $2.53B 0.66 -$200.32M -$0.97 N/A Roku $4.97B 4.23 $88.36M $1.33 107.09

Is TDOC or ROKU more profitable?

Roku has a net margin of 4.06% compared to Teladoc Health's net margin of -6.81%. Roku's return on equity of 7.64% beat Teladoc Health's return on equity. Company Net Margins Return on Equity Return on Assets Teladoc Health -6.81% -11.45% -5.54% Roku 4.06% 7.64% 4.61%

Does the media refer more to TDOC or ROKU?

In the previous week, Roku had 15 more articles in the media than Teladoc Health. MarketBeat recorded 24 mentions for Roku and 9 mentions for Teladoc Health. Teladoc Health's average media sentiment score of 0.49 beat Roku's score of 0.31 indicating that Teladoc Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 3 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Roku 8 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media prefer ZM or TDOC?

In the previous week, Zoom Communications had 12 more articles in the media than Teladoc Health. MarketBeat recorded 21 mentions for Zoom Communications and 9 mentions for Teladoc Health. Zoom Communications' average media sentiment score of 0.97 beat Teladoc Health's score of 0.49 indicating that Zoom Communications is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zoom Communications 12 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teladoc Health 3 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to TDOC or AMWL?

In the previous week, Teladoc Health had 3 more articles in the media than American Well. MarketBeat recorded 9 mentions for Teladoc Health and 6 mentions for American Well. Teladoc Health's average media sentiment score of 0.49 beat American Well's score of -0.12 indicating that Teladoc Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 3 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral American Well 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Teladoc Health (TDOC) Competitors

$9.19 -0.01 (-0.11%)

Closing price 07/2/2026 03:59 PM Eastern

Extended Trading

$9.06 -0.13 (-1.36%)

As of 07/2/2026 07:36 PM Eastern

Compare

TDOC vs. AMZN, CRSP, ROKU, ZM, and AMWL

Should you buy Teladoc Health stock or one of its competitors? MarketBeat compares Teladoc Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Teladoc Health include Amazon.com (AMZN), CRISPR Therapeutics (CRSP), Roku (ROKU), Zoom Communications (ZM), and American Well (AMWL).

How does Teladoc Health compare to Amazon.com?

Teladoc Health (NYSE:TDOC) and Amazon.com (NASDAQ:AMZN) are related companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

In the previous week, Amazon.com had 267 more articles in the media than Teladoc Health. MarketBeat recorded 276 mentions for Amazon.com and 9 mentions for Teladoc Health. Amazon.com's average media sentiment score of 0.88 beat Teladoc Health's score of 0.49 indicating that Amazon.com is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	3 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Amazon.com	160 Very Positive mention(s)	43 Positive mention(s)	43 Neutral mention(s)	23 Negative mention(s)	6 Very Negative mention(s)	Positive

76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 72.2% of Amazon.com shares are held by institutional investors. 0.7% of Teladoc Health shares are held by insiders. Comparatively, 8.9% of Amazon.com shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Amazon.com has a net margin of 12.22% compared to Teladoc Health's net margin of -6.81%. Amazon.com's return on equity of 19.92% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-6.81%	-11.45%	-5.54%
Amazon.com	12.22%	19.92%	9.86%

Teladoc Health currently has a consensus target price of $7.43, indicating a potential downside of 19.11%. Amazon.com has a consensus target price of $312.79, indicating a potential upside of 28.90%. Given Amazon.com's stronger consensus rating and higher possible upside, analysts plainly believe Amazon.com is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.24
Amazon.com	0 Sell rating(s)	3 Hold rating(s)	57 Buy rating(s)	0 Strong Buy rating(s)	2.95

Teladoc Health has a beta of 2.1, indicating that its stock price is 110% more volatile than the broader market. Comparatively, Amazon.com has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market.

Amazon.com has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Amazon.com, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.53B	0.66	-$200.32M	-$0.97	N/A
Amazon.com	$716.92B	3.64	$77.67B	$8.36	29.03

Summary

Amazon.com beats Teladoc Health on 14 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to CRISPR Therapeutics?

CRISPR Therapeutics (NASDAQ:CRSP) and Teladoc Health (NYSE:TDOC) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

69.2% of CRISPR Therapeutics shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 4.3% of CRISPR Therapeutics shares are owned by insiders. Comparatively, 0.7% of Teladoc Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Teladoc Health has higher revenue and earnings than CRISPR Therapeutics. CRISPR Therapeutics is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CRISPR Therapeutics	$1M	5,794.66	-$581.60M	-$6.22	N/A
Teladoc Health	$2.53B	0.66	-$200.32M	-$0.97	N/A

CRISPR Therapeutics currently has a consensus target price of $67.78, indicating a potential upside of 12.81%. Teladoc Health has a consensus target price of $7.43, indicating a potential downside of 19.11%. Given CRISPR Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe CRISPR Therapeutics is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CRISPR Therapeutics	1 Sell rating(s)	7 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.58
Teladoc Health	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.24

Teladoc Health has a net margin of -6.81% compared to CRISPR Therapeutics' net margin of -13,856.54%. Teladoc Health's return on equity of -11.45% beat CRISPR Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CRISPR Therapeutics	-13,856.54%	-25.66%	-20.39%
Teladoc Health	-6.81%	-11.45%	-5.54%

CRISPR Therapeutics has a beta of 1.71, suggesting that its stock price is 71% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.1, suggesting that its stock price is 110% more volatile than the broader market.

In the previous week, Teladoc Health had 2 more articles in the media than CRISPR Therapeutics. MarketBeat recorded 9 mentions for Teladoc Health and 7 mentions for CRISPR Therapeutics. CRISPR Therapeutics' average media sentiment score of 1.05 beat Teladoc Health's score of 0.49 indicating that CRISPR Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CRISPR Therapeutics	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Teladoc Health	3 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Teladoc Health beats CRISPR Therapeutics on 10 of the 17 factors compared between the two stocks.

How does Teladoc Health compare to Roku?

Teladoc Health (NYSE:TDOC) and Roku (NASDAQ:ROKU) are related companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

Teladoc Health has a beta of 2.1, meaning that its share price is 110% more volatile than the broader market. Comparatively, Roku has a beta of 2.01, meaning that its share price is 101% more volatile than the broader market.

Roku has a net margin of 4.06% compared to Teladoc Health's net margin of -6.81%. Roku's return on equity of 7.64% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-6.81%	-11.45%	-5.54%
Roku	4.06%	7.64%	4.61%

Roku has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Roku, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.53B	0.66	-$200.32M	-$0.97	N/A
Roku	$4.97B	4.23	$88.36M	$1.33	107.09

Teladoc Health currently has a consensus price target of $7.43, indicating a potential downside of 19.11%. Roku has a consensus price target of $153.71, indicating a potential upside of 7.92%. Given Roku's stronger consensus rating and higher probable upside, analysts clearly believe Roku is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.24
Roku	0 Sell rating(s)	16 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.41

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 86.3% of Roku shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by company insiders. Comparatively, 13.5% of Roku shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Roku had 15 more articles in the media than Teladoc Health. MarketBeat recorded 24 mentions for Roku and 9 mentions for Teladoc Health. Teladoc Health's average media sentiment score of 0.49 beat Roku's score of 0.31 indicating that Teladoc Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	3 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Roku	8 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Roku beats Teladoc Health on 14 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to Zoom Communications?

Zoom Communications (NASDAQ:ZM) and Teladoc Health (NYSE:TDOC) are related companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

Zoom Communications currently has a consensus target price of $109.33, suggesting a potential upside of 25.47%. Teladoc Health has a consensus target price of $7.43, suggesting a potential downside of 19.11%. Given Zoom Communications' stronger consensus rating and higher possible upside, equities analysts plainly believe Zoom Communications is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zoom Communications	0 Sell rating(s)	12 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.56
Teladoc Health	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.24

In the previous week, Zoom Communications had 12 more articles in the media than Teladoc Health. MarketBeat recorded 21 mentions for Zoom Communications and 9 mentions for Teladoc Health. Zoom Communications' average media sentiment score of 0.97 beat Teladoc Health's score of 0.49 indicating that Zoom Communications is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zoom Communications	12 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teladoc Health	3 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Zoom Communications has a beta of 1.01, indicating that its stock price is 1% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.1, indicating that its stock price is 110% more volatile than the broader market.

66.5% of Zoom Communications shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 8.8% of Zoom Communications shares are held by insiders. Comparatively, 0.7% of Teladoc Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Zoom Communications has a net margin of 41.99% compared to Teladoc Health's net margin of -6.81%. Zoom Communications' return on equity of 11.87% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zoom Communications	41.99%	11.87%	9.69%
Teladoc Health	-6.81%	-11.45%	-5.54%

Zoom Communications has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Zoom Communications, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zoom Communications	$4.87B	5.25	$1.90B	$6.81	12.80
Teladoc Health	$2.53B	0.66	-$200.32M	-$0.97	N/A

Summary

Zoom Communications beats Teladoc Health on 14 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to American Well?

Teladoc Health (NYSE:TDOC) and American Well (NYSE:AMWL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, risk, institutional ownership and media sentiment.

In the previous week, Teladoc Health had 3 more articles in the media than American Well. MarketBeat recorded 9 mentions for Teladoc Health and 6 mentions for American Well. Teladoc Health's average media sentiment score of 0.49 beat American Well's score of -0.12 indicating that Teladoc Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	3 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
American Well	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

American Well has lower revenue, but higher earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.53B	0.66	-$200.32M	-$0.97	N/A
American Well	$249.32M	0.62	-$95.70M	-$5.42	N/A

Teladoc Health has a net margin of -6.81% compared to American Well's net margin of -37.02%. Teladoc Health's return on equity of -11.45% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-6.81%	-11.45%	-5.54%
American Well	-37.02%	-32.11%	-24.12%

Teladoc Health has a beta of 2.1, meaning that its stock price is 110% more volatile than the broader market. Comparatively, American Well has a beta of 1.69, meaning that its stock price is 69% more volatile than the broader market.

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 56.1% of American Well shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by insiders. Comparatively, 12.8% of American Well shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Teladoc Health presently has a consensus target price of $7.43, suggesting a potential downside of 19.11%. American Well has a consensus target price of $7.20, suggesting a potential downside of 22.29%. Given Teladoc Health's stronger consensus rating and higher probable upside, analysts plainly believe Teladoc Health is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.24
American Well	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Teladoc Health beats American Well on 13 of the 16 factors compared between the two stocks.

Get Teladoc Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TDOC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TDOC vs. The Competition

Export

Metric	Teladoc Health	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$1.66B	$9.63B	$7.16B	$23.53B
Dividend Yield	N/A	1.62%	2.66%	3.98%
P/E Ratio	-9.47	27.84	28.02	31.55
Price / Sales	0.66	18.50	540.37	21.06
Price / Cash	5.11	114.69	49.26	25.36
Price / Book	1.18	6.19	10.96	4.81
Net Income	-$200.32M	$179.69M	$3.57B	$1.07B
7 Day Performance	9.89%	3.82%	2.12%	0.56%
1 Month Performance	30.45%	10.36%	5.25%	4.54%
1 Year Performance	11.60%	14.53%	33.29%	18.23%

Teladoc Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TDOC Teladoc Health	1.0596 of 5 stars	$9.19 -0.1%	$7.43 -19.1%	+11.6%	$1.66B	$2.53B	N/A	5,600	News Coverage Gap Down
AMZN Amazon.com	4.8729 of 5 stars	$232.79 -4.7%	$312.78 +34.4%	+8.8%	$2.50T	$716.92B	27.85	1,576,000	Trending News Analyst Forecast Insider Trade
CRSP CRISPR Therapeutics	2.1307 of 5 stars	$54.36 +0.5%	$67.78 +24.7%	+15.2%	$5.24B	$3.51M	N/A	460	News Coverage Analyst Downgrade Options Volume
ROKU Roku	3.105 of 5 stars	$135.20 -2.1%	$153.71 +13.7%	+61.6%	$19.93B	$4.74B	101.65	3,600	Trending News Insider Trade High Trading Volume
ZM Zoom Communications	4.7238 of 5 stars	$84.34 -2.3%	$109.33 +29.6%	+11.5%	$24.73B	$4.87B	12.38	7,438	News Coverage Positive News Analyst Forecast Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:TDOC) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Teladoc Health (TDOC) Competitors

TDOC vs. AMZN, CRSP, ROKU, ZM, and AMWL

How does Teladoc Health compare to Amazon.com?

Summary

How does Teladoc Health compare to CRISPR Therapeutics?

Summary

How does Teladoc Health compare to Roku?

Summary

How does Teladoc Health compare to Zoom Communications?

Summary

How does Teladoc Health compare to American Well?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TDOC vs. The Competition

Teladoc Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Teladoc Health (TDOC) Competitors

TDOC vs. AMZN, CRSP, ROKU, ZM, and AMWL

How does Teladoc Health compare to Amazon.com?

Does the media refer more to TDOC or AMZN?

Do insiders and institutionals believe in TDOC or AMZN?

Is TDOC or AMZN more profitable?

Do analysts rate TDOC or AMZN?

Which has more risk & volatility, TDOC or AMZN?

Which has higher valuation & earnings, TDOC or AMZN?

Summary

How does Teladoc Health compare to CRISPR Therapeutics?

Do insiders and institutionals have more ownership in CRSP or TDOC?

Which has preferable valuation and earnings, CRSP or TDOC?

Do analysts rate CRSP or TDOC?

Is CRSP or TDOC more profitable?

Which has more risk and volatility, CRSP or TDOC?

Does the media prefer CRSP or TDOC?

Summary

How does Teladoc Health compare to Roku?

Which has more risk and volatility, TDOC or ROKU?

Is TDOC or ROKU more profitable?

Which has preferable earnings and valuation, TDOC or ROKU?

Do analysts recommend TDOC or ROKU?

Do insiders & institutionals have more ownership in TDOC or ROKU?

Does the media refer more to TDOC or ROKU?

Summary

How does Teladoc Health compare to Zoom Communications?

Do analysts prefer ZM or TDOC?

Does the media prefer ZM or TDOC?

Which has more volatility & risk, ZM or TDOC?

Do insiders & institutionals hold more shares of ZM or TDOC?

Is ZM or TDOC more profitable?

Which has higher valuation and earnings, ZM or TDOC?

Summary

How does Teladoc Health compare to American Well?

Does the media refer more to TDOC or AMWL?

Which has preferable valuation & earnings, TDOC or AMWL?

Is TDOC or AMWL more profitable?

Which has more risk & volatility, TDOC or AMWL?

Do institutionals & insiders hold more shares of TDOC or AMWL?

Do analysts prefer TDOC or AMWL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TDOC vs. The Competition

Teladoc Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools